MENINGITIS STUDY P7
Who are we?
It takes about 12 years of research and development before a new medication is put on the market. Each medication must undergo an extensive testing process to ensure that it is both safe and effective. Humans are only involved in the very last steps of this long process, through clinical testing.
At Altasciences, we mainly conduct trials for generic formulations (copies) of medications which are already on the market, but we also conduct trials for new medications.
Participants are crucial to medical research. Without them, no new medication could be approved or improved.
Information
Who are we seeking?
We are looking for people who have been vaccinated against meningitis and pneumonia to participate in a clinical study in Montreal.
If you have not been vaccinated and are interested in receiving the vaccines, you could still be eligible.
Book a screening visit at our medical center at no cost. We will be able to give you an overall health assessment, which will help verify your eligibility to the clinical study.
How are participants compensated?
You will receive $100 for your participation in the screening visit.
If eligible, you will receive up to $9,000 for your participation in the clinical study.
All of the details will be explained by one of our agents over the phone.
** IMPORTANT **
You may only sign up if you have answered 'yes' to any of the below questions:
- Have you been vaccinated against pneumonia in the last 5 years?
- Have you been vaccinated against meningitis in the last 2,5 years?
- Are you interested in receiving the vaccines against meningitis and pneumonia?
Sign up for the screening visit
